Group 1 - Yinglian Co., Ltd. expects a net profit of 34.5 million to 37.5 million yuan for the first three quarters of 2025, representing a year-on-year increase of 1531% to 1673% [1] - China CNR Corporation signed major contracts totaling approximately 54.34 billion yuan, accounting for 22% of its expected revenue for 2024 [1] - Shengmei Shanghai reported a total order amount of 9.072 billion yuan, a year-on-year increase of 34.1% [2] Group 2 - Fulian Precision plans to increase capital in its subsidiary Jiangxi Shenghua with a total investment of 35.63 billion yuan, which is expected to constitute a major asset restructuring [3] - Aimeike has obtained a drug registration certificate for Minoxidil topical solution, which is used for treating male pattern baldness [4] - Guolin Technology is planning to acquire 91.07% of Kailianjie’s equity for cash, which is expected to constitute a major asset restructuring [5] Group 3 - Baicheng Co. plans to purchase 55% of Shanghai Canxi Engineering Equipment Co. and will suspend trading of its stock starting September 30, 2025 [6][7] - Diaowei is planning to acquire equity in Rongpai Semiconductor and has suspended trading of its stock [8] - Xiatun New Energy signed a strategic cooperation framework agreement with Zhongwei Co. to establish a long-term partnership in the supply chain for solid-state lithium battery materials [9] Group 4 - Lingyi Zhi Manufacturing is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy [10] - Baicheng Pharmaceutical received clinical trial approval for its innovative drug BIOS-0623-Z4, which targets cancer pain treatment [11] - Weide Information announced a preliminary transfer price of 40.33 yuan per share, representing a 26% discount to its closing price [12] Group 5 - Huayou Cobalt's subsidiary signed contracts with LGES for the supply of 76,000 tons of ternary precursor materials and 88,000 tons of ternary cathode materials from 2026 to 2030 [13] - Hubei Energy signed a cooperation agreement with the Xiangyang Municipal Government to invest 26.7 billion yuan in clean energy projects [14]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has initiated an investigation into *ST Muban and its actual controller, Liao Zhiyuan, for failing to disclose non-operating fund transactions as required by regulations [1][2][10] Group 1: Regulatory Actions - On September 29, *ST Muban announced that the CSRC decided to investigate Liao Zhiyuan for not disclosing non-operating fund transactions [1][2] - The CSRC's investigation follows a previous notice issued on July 25 regarding suspected false disclosures in the company's annual reports [1][10] - The Shanghai Stock Exchange publicly criticized *ST Muban and Liao Zhiyuan for multiple violations related to information disclosure and operational compliance [4][10] Group 2: Financial Data and Risks - As of September 29, *ST Muban's stock price was 9.42 yuan per share, with a total market capitalization of 4.085 billion yuan, reflecting a 5.02% increase [1] - The company experienced a cumulative stock price increase of 21.71% over four consecutive trading days, despite no significant changes in its operations [11] - For the first half of 2025, *ST Muban reported revenue of 141 million yuan, a decrease of 33.85% compared to the same period last year, and a net loss of 212 million yuan [13][14] Group 3: Related Party Transactions - *ST Muban provided 1.68 billion yuan to its controlling shareholder, Muban Holdings, in 2024, with non-operating fund occupation balances of 1.08 billion yuan by the end of 2024 [8][9] - The company also provided 2.61 billion yuan to other related parties in 2024, with non-operating fund occupation balances of 484.56 million yuan by the end of 2024 [9][10] Group 4: Future Listing Risks - *ST Muban faces the risk of delisting if its 2025 annual revenue falls below 300 million yuan, and if it receives a negative audit opinion regarding internal controls [15] - The company has been under risk warning since May 6 due to negative net profit for the 2024 fiscal year [11][15]

*ST沐邦（603398）(603398.SH)发布公告，公司实际控制人廖志远先生于2025年9月29日收到中国证券 监督管理委员会(简称"中国证监会")《立案告知书》(编号：证监立案字0252025005号)。因廖志远先生 涉嫌未按规定披露非经营性资金往来，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》 等法律法规，中国证监会决定对廖志远先生立案。 ...

Macro Dynamics - As of June 2025, China's banking sector has foreign financial assets totaling $17,721 billion and foreign liabilities of $15,377 billion, resulting in a net foreign asset of $2,344 billion. The net liabilities in RMB amount to $3,171 billion, while net assets in foreign currencies total $5,515 billion. The breakdown of foreign financial assets shows that loans and deposits account for $10,638 billion (60%), bonds for $4,526 billion (26%), and other assets for $2,557 billion (14%) [2]. Visa and Immigration Policies - China has introduced a new K visa category aimed at promoting exchanges and cooperation among young scientific and technological talents, with details to be announced by Chinese embassies and consulates [3]. - Starting September 29, South Korea has implemented a visa waiver policy for group tourists from China, allowing groups of three or more to enter without a visa for up to 15 days [5]. Financial Institutions - Roadhuas Securities has been fined HKD 2.1 million by the Hong Kong Securities and Futures Commission for improper handling of client funds, which included failing to maintain sufficient funds in independent client accounts on 12 occasions between February 2021 and July 2022 [6]. Market Data - On September 29, the A-share market saw all major indices rise, with the Shanghai Composite Index increasing by 0.9%, the Shenzhen Component by 2.05%, and the ChiNext Index by 2.74%. The total trading volume across the Shanghai and Shenzhen exchanges was CNY 21,781 billion, an increase of CNY 120 billion from the previous day [7]. - The margin financing balance in the two markets decreased by CNY 19.253 billion as of September 26, with the Shanghai Stock Exchange reporting a balance of CNY 12,188.55 billion and the Shenzhen Stock Exchange reporting CNY 11,815.43 billion [8]. Company Dynamics - China CNR Corporation announced several major contracts signed between July and September 2025, totaling approximately CNY 543.4 billion, which represents about 22% of the company's projected revenue for 2024 [11]. - The actual controller of *ST Muban has been placed under investigation by the China Securities Regulatory Commission for failing to disclose non-operational fund transactions, with the stock experiencing a 21.71% increase over four consecutive trading days [12]. - Visa has appointed Elaine Chang as the new president for the Greater China region, succeeding Shirley Yu, who is set to retire at the end of the year [13]. - JD Health announced the resignation of its CEO, Jin Enlin, effective September 29, 2025, with Cao Dong appointed as the new CEO [14]. - Hainan Duty-Free Company has increased its registered capital from CNY 1.2 billion to CNY 1.7 billion, marking a 42% increase [15][16]. - AstraZeneca plans to list its shares on the New York Stock Exchange while retaining its headquarters in the UK [17]. - XGIMI Technology has submitted a listing application to the Hong Kong Stock Exchange, with CICC as the exclusive sponsor [18].

突发。 公告称，廖志远及公司将积极配合中国证监会的相关工作，并严格按照监管要求履行信息披露义务。 *ST沐邦（603398）9月29日晚间公告，公司实际控制人廖志远于2025年9月29日收到中国证监会《立案 告知书》，因廖志远涉嫌未按规定披露非经营性资金往来，根据《中华人民共和国证券法》《中华人民 共和国行政处罚法》等法律法规，中国证监会决定对廖志远立案。 更早之前，公司于2025年7月25日收到中国证监会《立案告知书》。因公司涉嫌年报等定期报告财务数 据虚假披露等违法行为，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规， 中国证监会决定对公司立案。截至本公告披露日，公司未收到中国证监会就上述立案事项的结论性意见 或决定。 同日（9月29日），*ST沐邦还发布了关于股票交易的风险提示公告。公告称，公司股票自2025年9月24 日至9月29日，连续四个交易日涨停，累计涨幅21.71%。公司生产经营未发生重大变化，股价短期内上 涨过快，脱离基本面，可能存在下跌风险。敬请广大投资者注意二级市场交易风险，理性决策，审慎投 资。 盘面上看，9月以来，*ST沐邦股价涨幅超过了50%。 （文章来源：证券 ...

*ST沐邦（603398）9月29日晚间公告，公司实际控制人廖志远于2025年9月29日收到中国证监会《立案告知书》，因廖志远涉嫌 未按规定披露非经营性资金往来，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定 对廖志远立案。 公告称，廖志远及公司将积极配合中国证监会的相关工作，并严格按照监管要求履行信息披露义务。 同日(9月29日)，*ST沐邦还发布了关于股票交易的风险提示公告。公告称，公司股票自2025年9月24日至9月29日，连续四个交易 日涨停，累计涨幅21.71%。公司生产经营未发生重大变化，股价短期内上涨过快，脱离基本面，可能存在下跌风险。敬请广大投 资者注意二级市场交易风险，理性决策，审慎投资。 突发。 盘面上看，9月以来，*ST沐邦股价涨幅超过了50%。 值得一提的是，*ST沐邦存在终止上市的风险。根据公告，因公司2024年度净利润为负，且扣除与主营业务无关的业务收入和不 具备商业实质的收入后的营业收入低于3亿元，公司股票于2025年5月6日被上交所实施退市风险警示。同时，公司2024年度内部 控制被出具否定意见的审计报告，涉及收入确认、募集资金管理、关联交易 ...

突发。 *ST沐邦（603398）9月29日晚间公告，公司实际控制人廖志远于2025年9月29日收到中国证监会《立案告知书》，因廖志远涉嫌未按规定披露非经营性资金 往来，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对廖志远立案。 公司2025年1—6月营业收入为1.41亿元、净利润为亏损2.13亿元。根据《上海证券交易所股票上市规则》第9.3.7条等相关规定，如公司2025年度营业收入 低于3亿元且利润总额、扣非前后净利润三者孰低者为负值，或者公司2025年度内部控制被出具无法表示意见或否定意见的审计报告，公司股票将在2025年 年报披露后终止上市。 此外，公司于2025年7月23日收到江西证监局《关于对江西沐邦高科股份有限公司、江西沐邦新能源控股有限公司、江西豪安能源科技有限公司、廖志远和 张忠安采取责令改正措施并对汤晓春和刘毅采取出具警示函措施的决定》（［2025］19号），公司以预付设备款和工程款等方式，通过第三方向控股股东和 其他关联方提供资金，其中：2024年向控股股东提供资金1.68亿元，截至2024年末，控股股东非经营性资金占用余额1.07亿元，截至2025 ...

智通财经APP讯，*ST沐邦(603398.SH)发布公告，公司实际控制人廖志远先生于2025年9月29日收到中 国证券监督管理委员会(简称"中国证监会")《立案告知书》(编号：证监立案字0252025005号)。因廖志 远先生涉嫌未按规定披露非经营性资金往来，根据《中华人民共和国证券法》《中华人民共和国行政处 罚法》等法律法规，中国证监会决定对廖志远先生立案。 ...

9月29日晚，*ST沐邦公告称，公司实际控制人廖志远于2025年9月29日收到中国证监会《立案告知 书》。因廖志远涉嫌未按规定披露非经营性资金往来，根据相关法律法规，中国证监会决定对廖志远立 案。 *ST沐邦表示，廖志远及公司将积极配合中国证监会的相关工作，并严格履行信息披露义务。敬请广大 投资者关注公司相关公告，理性投资，注意投资风险。 二级市场上，*ST沐邦涨停，收获四连板。 *ST沐邦(603398) W 闭市 09-29 15:00:04 0 /17 额 1.55亿 股本4.34亿 市盈 -3.6 万得 盘口 换 3.84% 市值140.8亿 市净 5.20 +5.02% +0.45 分时 五日 (0) 叠加 设均线 MA 5:8.56↑ 10:7.90↑ 20:7.14↑ 前复权 9.85 7.27 4.69 2025-08-11 08-21 09-03 09-16 09-29 ...

*ST沐邦表示，廖志远及公司将积极配合中国证监会的相关工作，并严格履行信息披露义务。敬请广大投资者关注公司相关公告，理性投资，注意投资风 险。 9月29日晚，*ST沐邦公告称，公司实际控制人廖志远于2025年9月29日收到中国证监会《立案告知书》。因廖志远涉嫌未按规定披露非经营性资金往 来，根据相关法律法规，中国证监会决定对廖志远立案。 二级市场上，*ST沐邦涨停，收获四连板。 *ST沐邦(603398) ( W 闭市 09-29 15:00:04 额 1.55亿 股本4.34亿 市盈 -3.6 万得 盘口 换 3.84% 市值140.8亿 市净 5.20 +0.45 +5.02% 五日 日K 分时 更多 0 叠加 设均线 MA 5:8.56↑ 10:7.90↑ 20:7.14↑ 前复权 9.85 7.27 4.69 and and and the successful and the support of the successful and and and and and and 2025-08-11 08-21 09-03 09-16 09-29 ...